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Abstract: Metabolic syndrome is a cluster of disorders that increase the risk of cardiovascular disease
and diabetes. This study has investigated the responses to rind of yellow mangosteen (Garcinia dulcis),
usually discarded as waste, in a rat model of human metabolic syndrome. The rind contains higher
concentrations of phytochemicals (such as garcinol, morelloflavone and citric acid) than the pulp.
Male Wistar rats aged 8–9 weeks were fed either corn starch diet or high-carbohydrate, high-fat diet
for 16 weeks, which were supplemented with 5% freeze-dried G. dulcis fruit rind powder during
the last 8 weeks. We characterised metabolic, cardiovascular, liver and gut microbiota parameters.
High-carbohydrate, high-fat diet-fed rats developed abdominal obesity, hypertension, increased
left ventricular diastolic stiffness, decreased glucose tolerance, fatty liver and reduced Bacteroidia
with increased Clostridia in the colonic microbiota. G. dulcis fruit rind powder attenuated these
changes, improved cardiovascular and liver structure and function, and attenuated changes in
colonic microbiota. G. dulcis fruit rind powder may be effective in metabolic syndrome by appetite
suppression, inhibition of inflammatory processes and increased fat metabolism, possibly related to
changes in the colonic microbiota. Hence, we propose the use of G. dulcis fruit rind as a functional
food to ameliorate symptoms of metabolic syndrome.
Keywords: metabolic syndrome; Garcinia dulcis; citric acid; garcinol; morelloflavone; microbiota
1. Introduction
The genus Garcinia includes more than 250 species of shrubs and trees of the Clusiaceae or
Guttiferae family that grow in lowland tropical forests. Species include G. mangostana (purple
mangosteen), G. cambogia (Malabar tamarind) and G. humilis (achacha or Bolivian mangosteen) [1].
The yellow mangosteen or G. dulcis (Roxb.) Kurz is native to Borneo, Java, the Philippines, Malaya and
southern Thailand and cultivated throughout Southeast Asia and the American tropical regions [2].
In Australia, G. dulcis is usually restricted to north Queensland, where it grows in rainforests from
the Melville range, Cape York Peninsula, to the Torres Strait islands [3] but is also grown around
South East Queensland [4]. The young fruit is green but turns yellow when ripe. The ripe juicy pulp
tastes sour to sweet [5]. The crushed fruit is used as an expectorant to clear sputum, alleviate cough,
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treat scurvy and as a mild laxative [2,5,6]. An extract of G. dulcis fruit showed hepatoprotective and
anti-proliferative properties [7,8].
The major bioactive compounds in the fruits of G. dulcis were morelloflavone and garcinol [9].
Morelloflavone has hypocholesterolaemic and anti-atherogenic properties [10,11]. Garcinol showed
anti-inflammatory, anti-oxidant, anti-cancer, anti-diabetic and cardioprotective properties and
protection against allergy and neurodegenerative diseases [12]. In addition, morelloflavone, garcinol
and xanthone derivatives in G. dulcis have anti-inflammatory, anti-oxidant, anti-viral, anti-cancer and
hypocholesterolaemic properties [2,9].
Metabolic syndrome is a collection of symptoms such as abdominal obesity, hypertension,
dyslipidaemia, insulin resistance and a pro-thrombotic state [13,14]. Abdominal obesity was measured
by increased waist circumference; dyslipidaemia was measured by increased plasma triglycerides and
reduced HDL-cholesterol concentrations, and insulin resistance was measured by high fasting plasma
glucose and insulin concentrations. Further, changes in the composition of the gut microbiota have
been associated with the pathogenesis of metabolic syndrome [15]. Increased consumption of fruit and
vegetables could prevent chronic diseases such as cardiovascular disease and prevent body weight
gain [16]. Additionally, plant-based foods reduced metabolic syndrome risk [17].
In this study, we evaluated the reversal by G. dulcis rind of the metabolic, cardiovascular, liver
and gut microbiota changes produced by intervention with food containing high simple sugars and
saturated and trans fats in rats. This model mimics metabolic syndrome in humans [18]. The rind of
Garcinia fruits, usually regarded as a waste product, was chosen because of its higher concentrations of
potentially bioactive phytochemicals compared to the pulp [19,20]. Parameters that were analysed
included metabolic parameters such as body weight, fat deposition, lipid profiles, adipocyte histology,
glucose tolerance and the gut microbiota, as well as cardiovascular and liver parameters such as blood
pressure, left ventricular diastolic stiffness, plasma liver enzymes and organ structure. We hypothesised
that G. dulcis rind will reverse the symptoms in diet-induced rat model of metabolic syndrome consistent
with the reported bioactivity of garcinol, morelloflavone and citric acid that are present in the rind.
2. Results
2.1. Weight and Phytochemical Analysis of G. dulcis Rind, Pulp and Seed
The ripe fruit was about 8 cm in diameter with 1 cm thick rind and weighed 161 ± 7 g (n = 6;
Figure 1A,B). Wet weights of the rind, pulp and seed were 64 ± 3 g, 62 ± 4 g and 35 ± 1 g,
respectively. The total moisture contents of the rind, pulp and seed were 83%, 82% and 49%,
respectively. The high-performance liquid chromatography (HPLC) chromatograms for pulp, rind
and seed are given in Figure 1C. The rind contained benzophenones (7.86% w/w) including garcinol
(6.35% w/w), as well as citric acid (24% w/w) and morelloflavone (0.55% w/w). The pulp contained
benzophenones (3.54% w/w) including garcinol (2.87% w/w), as well as citric acid (19% w/w) and
morelloflavone (0.11% w/w). The seeds contained morelloflavone (2.9%) and diprenyl-xanthone
derivatives, but citric acid and benzophenones were not detected.
2.2. Metabolic Parameters
The consumption of food in high-carbohydrate, high-fat diet-fed rats (H) was lower than in corn
starch diet-fed rats (C) (Table 1). This translates to lower intakes of garcinol, morelloflavone and citric
acid in high-carbohydrate, high-fat diet-fed rats treated with G. dulcis (HGD) compared to corn starch
diet-fed rats treated with G. dulcis (CGD) (Table 1). G. dulcis treatment reduced food intake in CGD and
HGD rats, but water intake was unchanged (Table 1). The energy intakes in H rats were higher than in
C rats due to the higher energy density of high-carbohydrate, high-fat diet, but HGD and CGD rats
had lower energy intake than H and C rats, respectively, due to decreased food intake (Table 1).
At 16 weeks, H rats showed increased abdominal fat pads, abdominal circumference and total
body fat mass (Table 1). Both HGD and CGD rats showed declining body weights from the beginning
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of the treatment period (Figure 2A). HGD rats at 16 weeks had lower body weight (Figure 2A), feed
efficiency, abdominal circumference, retroperitoneal fat, epididymal fat, omental fat, total abdominal fat,
visceral adiposity index, bone mineral content, bone mineral density and body mass index compared
to H rats (Table 1). Similarly, CGD rats had lower body weight (Figure 2A), feed efficiency, abdominal
circumference, body fat mass, retroperitoneal fat, epididymal fat, omental fat, total abdominal fat
and visceral adiposity index compared to C rats (Table 1). Mean adipocyte area was higher in H rats
compared to C rats; adipocyte area was lower in both CGD and HGD rats (Table 1; Figures 2B and
3A–D). The adipocyte area distribution showed more adipocytes with larger area in H rats compared
to HGD, C and CGD rats (Table 1, Figure 2B).
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Figure 1. (A) Whole Garcinia dulcis fruit, (B) Garcinia dulcis rind and pulp and (C) high-performance
liquid chromatography profile at 210 nm of Garcinia dulcis pulp, rind and seed.
After 8 weeks, oral glucose response and insulin response indicated insulin resistance in H rats
compared to C rats (Table 1). At 16 weeks, HGD showed improvement in both oral glucose response
and insulin response while CGD rats showed only reduction in glucose response but not insulin
response compared to C rats (Table 1). Plasma catalase activity was increased in H rats compared to C
rats and was unchanged by the treatment (Table 1). Faecal lipid content was higher in H and HGD rats
compared to C rats and lower in CGD rats (Table 1).
Intervention with G. dulcis decreased heat production in both CGD and HGD rats compared to C
and H rats, respectively (Table 1). Respiratory exchange ratio values in C and H rats were consistent
with the foods and were unchanged by G. dulcis intervention (Table 1). Total plasma cholesterol
concentrations in CGD rats were lower than C, H and HGD rats. HGD rats had lower concentrations
of triglycerides and non-esterified fatty acids than H rats (Table 1).
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Table 1. Effects of Garcinia dulcis rind on physiological, metabolic and cardiovascular parameters.
Variables C CGD H HGD
p Value
Diet Treatment Interaction
Physiological Parameters
Initial body weight, g 338 ± 0.9a 339 ± 0.7a 337 ± 0.7a 337 ± 0.7a 0.35 0.46 0.32
8-week body weight, g 355 ± 6.6b 362 ± 7.0b 423 ± 6.4a 422 ± 10a <0.0001 0.75 0.61
16-week body weight, g 404 ± 8b 306 ± 6d 508 ± 11a 362 ± 10c <0.0001 <0.0001 0.011
Food intake, g/day 41.2 ± 2.3a 26.3 ± 2.3b 27.0 ± 2.5b 20.1 ± 1.9b 0.0001 <0.0001 0.10
Water intake, g/day 23.6 ± 2.6a 28.7 ± 2.9a 28.6 ± 6.0a 37.6 ± 4.5a 0.10 0.09 0.64
Garcinol intake, mg/kg/day - 210 ± 7 - 130 ± 8 - - -
Citric acid intake, mg/kg/day - 780 ± 27 - 480 ± 23 - - -
Morelloflavone intake, mg/kg/day - 7.3 ± 0.2 - 5.4 ± 0.1 - - -
Energy intake, kJ/day 462 ± 28b 318 ± 10c 603 ± 52a 501 ± 12b <0.0001 0.0002 0.49
Feed efficiency (8–16 weeks), g/kJ 0.10 ± 0.01a −0.18 ± 0.02b 0.15 ± 0.02a −0.11 ± 0.02b 0.002 <0.0001 0.58
Body weight gained (8–16 weeks), % 13.7 ± 1.0b −15.4 ± 0.8c 20.1 ± 2.8a −13.0 ± 2.2c 0.024 <0.0001 0.29
Abdominal circumference 8 weeks, cm 16.1 ± 0.2b 16.6 ± 0.3b 19.8 ± 0.5a 20.4 ± 0.5a <0.0001 0.18 0.91
Abdominal circumference 16 weeks, cm 18.4 ± 0.4b 15.0 ± 0.2d 22.6 ± 0.4a 16.8 ± 0.4c <0.0001 <0.0001 0.001
Whole body lean mass 8 weeks, g 283 ± 12a 300 ± 4a 310 ± 6a 302 ± 5a 0.047 0.56 0.09
Whole body lean mass 16 weeks, g 289 ± 10a 267 ± 5a 297 ± 8a 265 ± 13a 0.71 0.007 0.62
Whole body fat mass 8 weeks, g 57 ± 5b 51 ± 8b 94 ± 8a 105 ± 19a 0.002 0.86 0.55
Whole body fat mass 16 weeks, g 96 ± 9b 23 ± 3c 203 ± 12a 84 ± 6b <0.0001 <0.0001 0.012
Bone mineral content 8 weeks, g 11.0 ± 0.6a 10.6 ± 0.5a 11.8 ± 0.3a 12.0 ± 0.6a 0.025 0.83 0.81
Bone mineral content 16 weeks, g 12.4 ± 0.5b 10.0 ± 0.2c 16.1 ± 0.5a 11.8 ± 0.3b <0.0001 <0.0001 0.019
Bone mineral density 8 weeks, g/cm2 0.163 ± 0.004a 0.160 ± 0.005a 0.168 ± 0.004a 0.164 ± 0.002a 0.26 0.39 0.87
Bone mineral density 16 weeks, g/cm2 0.173 ± 0.004b 0.165 ± 0.003b 0.185 ± 0.003a 0.162 ± 0.003b <0.0001 0.18 0.027
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Table 1. Cont.
Variables C CGD H HGD
p Value
Diet Treatment Interaction
Body mass index 16 weeks, g/cm2 0.63 ± 0.02b 0.54 ± 0.02c 0.77 ± 0.02a 0.60 ± 0.02b <0.0001 <0.0001 0.052
Retroperitoneal fat, mg/mm tibial length 255 ± 22b 71 ± 7d 497 ± 33a 160 ± 18c <0.0001 <0.0001 0.001
Epididymal fat, mg/mm tibial length 101 ± 16b 39 ± 6c 165 ± 18a 49 ± 5c 0.006 <0.0001 0.040
Omental fat, mg/mm tibial length 159 ± 14b 66 ± 4d 260 ± 11a 115 ± 8c <0.0001 <0.0001 0.015
Total abdominal fat, mg/mm tibial length 515 ± 45b 176 ± 13d 951 ± 49a 325 ± 29c <0.0001 <0.0001 0.001
Visceral adiposity index, % 5.84 ± 0.43b 2.60 ± 0.20d 8.65 ± 0.39a 4.24 ± 0.37c <0.0001 <0.0001 0.11
Kidney wet weight, mg/mm tibial length 50.2 ± 1.2b 40.7 ± 1.2c 56.0 ± 1.6a 47.1 ± 1.3b <0.0001 <0.0001 0.82
Heat production 16 weeks, kcal/hour 4.06 ± 0.40a 2.06 ± 0.14b 4.20 ± 0.49a 3.59 ± 0.31a 0.029 0.003 0.06
Heat production area under the curve 16
weeks, (kcal/hour) × minutes 2878 ± 212ab 1419 ± 76
c 3193 ± 97a 2500 ± 201b 0.002 <0.0001 0.053
Respiratory exchange ratio 16 weeks 0.973 ± 0.010a 0.986 ± 0.024a 0.886 ± 0.017b 0.898 ± 0.037b 0.012 0.66 0.99
Respiratory exchange ratio area under the
curve 16 weeks 700 ± 9
a 707 ± 16a 618 ± 15b 631 ± 18b 0.0005 0.48 0.82
Mean liver fat vacuoles area, µm2 14.1 ± 0.8c 9.8 ± 0.5c 150.1 ± 13.6a 73.0 ± 8.8b <0.0001 <0.0001 <0.0001
Mean retroperitoneal adipocyte area, µm2 4299 ± 120b 2290 ± 67c 9966 ± 195a 4115 ± 326b <0.0001 <0.0001 <0.0001
Plasma Biochemistry and Glucose Response
Plasma alanine transaminase activity, U/L 28.4 ± 4.0b 33.8 ± 2.7a 42.3 ± 5.0a 39.1 ± 5.1a 0.025 0.89 0.28
Plasma aspartate transaminase activity,
U/L 83.0 ± 8.0b 86.5 ± 9.0b 173.9 ± 24.0
a 91.4 ± 6.6b 0.001 0.007 0.003
Plasma total cholesterol, mmol/L 1.37 ± 0.07a 0.95 ± 0.06b 1.66 ± 0.10a 1.50 ± 0.12a <0.0001 0.003 0.16
Plasma triglycerides, mmol/L 0.45 ± 0.05b 0.25± 0.02b 1.15 ± 0.17a 0.35 ± 0.08b 0.0008 <0.0001 0.009
Plasma non-esterified fatty acids, mmol/L 0.87 ± 0.18b 0.35 ± 0.04c 3.25 ± 0.17a 0.80 ± 0.16b <0.0001 <0.0001 <0.0001
Basal blood glucose 8 weeks, mmol/L 2.4 ± 0.1b 2.3 ± 0.1b 3.1 ± 0.1a 3.0 ± 0.1a <0.0001 0.33 1.0
Basal blood glucose 16 weeks, mmol/L 2.6 ± 0.1ab 2.4 ± 0.2b 3.0 ± 0.1a 2.8 ± 0.1ab 0.003 0.13 1.0
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Table 1. Cont.
Variables C CGD H HGD
p Value
Diet Treatment Interaction
Blood glucose area under the curve 8
weeks, mmol/L × minutes 488 ± 9b 494 ± 11b 596 ± 13
a 585 ± 7a <0.0001 0.82 0.43
Blood glucose area under the curve 16
weeks, mmol/L × minutes 466 ± 17
c 401 ± 17d 602 ± 24a 544 ± 19b <0.0001 0.003 0.86
Insulin response area under the curve 8
weeks, mmol/L × minutes 175 ± 23b 200 ± 34b 416 ± 55
a 413 ± 12a <0.0001 0.78 0.72
Insulin response area under the curve 16
weeks, mmol/L × minutes 149 ± 19
c 154 ± 22c 373 ± 24a 281 ± 21b <0.0001 0.028 0.017
Liver wet weight, mg/mm tibial length 231 ± 8b 212 ± 7b 358 ± 15a 341 ± 13a <0.0001 0.14 0.91
Liver glycogen, mg/g 12.9 ± 0.4a 4.8 ± 0.5c 13.9 ± 0.4a 8.4 ± 1.2b 0.002 <0.0001 0.08
Plasma catalase activity, kU/L 39.0 ± 4.7b 45.6 ± 6.0ab 56.9 ± 8.1a 56.9 ± 8.8a 0.030 0.69 0.69
Plasma C-reactive protein, µg/mL 432 ± 5b 355 ± 22c 506 ± 8a 376 ± 19c 0.034 0.0002 0.19
Faecal lipid content, mg/g 21.8 ± 1.5b 8.1 ± 0.4c 43.3 ± 1.6a 42.1 ± 5.4a <0.0001 0.015 0.039
Cardiovascular Variables
Systolic blood pressure 8 weeks, mmHg 116 ± 3b 121 ± 2b 133 ± 4a 132 ± 3a <0.0001 0.45 0.24
Systolic blood pressure 16 weeks, mmHg 117 ± 2bc 111 ± 3c 135 ± 2a 121 ± 5b <0.0001 0.006 0.43
Left ventricle + septum wet weight,
mg/mm tibial length 23.3 ± 1.4
a 18.9 ± 0.7a 22.8 ± 1.4a 18.5 ± 0.8a 0.72 0.0005 0.99
Right ventricle wet weight, mg/mm
tibial length 4.1 ± 0.2ab 3.6 ± 0.3b 4.7 ± 0.2
a 4.0 ± 0.3ab 0.027 0.059 0.74
Left ventricular diastolic stiffness (κ) 21.6 ± 0.2b 21.9 ± 0.9b 26.7 ± 0.6a 22.5 ± 0.6b <0.0001 0.004 0.001
Values are expressed as mean ± SEM, n = 8–12. Means with different superscripts (a, b, c or d) differ, p < 0.05. C, corn starch diet-fed rats; CGD, corn starch diet-fed rats supplemented with
5% Garcinia dulcis rind powder; H, high-carbohydrate, high-fat diet-fed rats; HGD, high-carbohydrate, high-fat diet-fed rats supplemented with 5% Garcinia dulcis rind powder.
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2.3. Cardiovascular Structure and Function
H rats developed an increased systolic blood pressure at weeks 8 and 16 compared to C rats
(Table 1). At week 16, HGD rats had lower systolic blood pressure compared to H rats (Table 1). Left
ventricular diastolic stiffness was lower in HGD rats than in H rats, which indicated that G. dulcis
treatment improved heart function (Table 1). Infiltration of inflammatory cells and collagen deposition
were lower in the left ventricles of C and CGD rats (Figure 3E,F,I,J). Infiltration of inflammatory cells
and perivascular collagen deposition was higher in H rats and lower in HGD rats to be similar to C
and CGD rats (Figure 3G,H,K,L).
Int. J. Mol. Sci. 2019, 20, x  7 of 29 
 
2.3. Cardiovascular Structure and Function 
H rats developed an increased systolic blood pressure at weeks 8 and 16 compared to C rats 
(Table 1). At week 16, HGD rats had lower systolic blood pressure compared to H rats (Table 1). Left 
ventricular diastolic stiffness was lower in HGD rats than in H rats, which indicated that G. dulcis 
treatment improved heart function (Table 1). Infiltration of inflammatory cells and collagen 
deposition were lower in the left ventricles of C and CGD rats (Figure 3E,F,I,J). Infiltration of 
inflammatory cells and perivascular collagen deposition was higher in H rats and lower in HGD rats 
to be similar to C and CGD rats (Figure 3G,H,K,L). 
 
Figure 2. (A) Weekly body weight of C, CGD, H and HGD rats; dotted line signifies when treatment 
started for CGD and HGD rats, (B) Distribution of retroperitoneal adipocyte sizes. C, corn starch diet-
fed rats; CGD, corn starch diet-fed rats supplemented with 5% Garcinia dulcis rind powder; H, high-
carbohydrate, high-fat diet-fed rats; HGD, high-carbohydrate, high-fat diet-fed rats supplemented 
with 5% Garcinia dulcis rind powder. 
 
Figure 3. Haematoxylin and eosin staining of adipocytes (A–D; magnification ×10; scale bar = 400 
µm); haematoxylin and eosin staining of left ventricle indicating inflammatory cells as dark spots 
outside myocytes and in vascular endothelium marked as arrow (E–H; magnification ×20; scale bar = 
200 µm); and picrosirius red staining of left ventricle indicating collagen deposition as red stain 
marked by arrows (I–L; magnification ×12.6; scale bar = 100 µm). Corn starch diet-fed rats (A,E,I), 
corn starch diet-fed rats treated with Garcinia dulcis rind powder (B,F,J), high-carbohydrate, high-fat 
Figure 2. (A) Weekly body weight of C, CGD, H and HG r t li e signifies when treatment
started for CGD and HGD rat , istribution of retroperitoneal adipocyte sizes. C, corn starch
diet-fed rats; CGD, corn starch di t-fed rats supplemented with 5% Garcin a dulcis rind powder; H,
high-carbohydrate, high-fat diet-fed rats; HGD, high-carbohydrate, high-fat diet-fed rat su plemented
with 5% Garcinia dulcis rind powder.
Int. J. Mol. Sci. 2019, 20, x  7 of 29 
 
2.3. Cardiovascular Structure and Function 
H rats developed an increased systolic blood pressure at weeks 8 and 16 compared to C rats 
(Table 1). At week 16, HGD rats had lower systolic blood pressure compared to H rats (Table 1). Left 
ventricular diastolic stiffness was lower in HGD rats than in H rats, which indicated that G. dulcis 
treatment improved heart function (Table 1). Infiltration of inflammatory cells and collagen 
d position were ow r in the left ventricles of C and CGD rats (Figure 3E,F,I,J). Infiltration of 
inflammatory cells and perivascular collagen deposition was higher in H rats and lower in HGD rats 
to be similar to C and CGD rats (Figure 3G,H,K,L). 
 
Figure 2. (A) eekly bo y eig t of , CG ,   GD rats; dotted line signifies when treatment 
started for C  and  rats, (B) istribution of retroperitoneal adipocyte sizes. C, corn starch diet-
fed rats; CGD, corn starch diet-fed rats supplemented with 5% Garcinia dulcis rind powder; H, high-
carbohydrate, high-fat diet-fed rats; HGD, high-carbohydrate, high-fat diet-fed rats supplemented 
with 5% Garcinia dulcis rind powder. 
 
Figure 3. Haematoxylin and eosin staining of adipocytes (A–D; magnification ×10; scale bar = 400 
µm); haematoxylin and eosin staining of left ventricle indicating inflammatory cells as dark spots 
outside myocytes and in vascular endothelium marked as arrow (E–H; magnification ×20; scale bar = 
200 µm); and picrosirius red staining of left ventricle indicating collagen deposition as red stain 
marked by arrows (I–L; magnification ×12.6; scale bar = 100 µm). Corn starch diet-fed rats (A,E,I), 
corn starch diet-fed rats treated with Garcinia dulcis rind powder (B,F,J), high-carbohydrate, high-fat 
Figure 3. Haematoxylin a d eosin staining of adipocytes (A–D; magnification ×10; scale bar = 4 µm);
haematoxylin nd eosin staini g of left ventricle indicating inflamm tory cells as d rk spots utside
myocytes and in vascular endothelium marked as arrow (E–H; magnification ×20; scale bar = 200 µm);
and picrosirius red staining of left ventricle indicating collagen deposition as red stain marked by
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2.4. Liver Structure and Function
Compared to C rats, H rats showed higher infiltration of inflammatory cells in the liver
(Figure 4A,C); infiltration was reduced in HGD rats (Figure 4D). Liver fat deposition was higher in H
rats but much reduced in HGD rats (Figure 4C,D). C and CGD rats had minimal liver fat deposition
(Figure 4A,B). Picrosirius red staining showed lower collagen deposition in C, CGD and HGD liver,
notably in perivascular area (Figure 4E,F,H). Oil red O staining confirmed the reduced fat deposition
in C, CGD and HGD liver (Figure 4I,J,L). Liver glycogen content was reduced in CGD and HGD
rats compared to C and H rats, respectively (Table 1). Plasma alanine transaminase activities were
unchanged by diet or intervention, but aspartate transaminase activities were lower in HGD rats
compared to H rats (Table 1).
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2.5. Gut Structure and Microbiota
Gastrointestinal histology showed no differences between the groups, demonstrated by normal
crypt depth, villi length, goblet cells and lack of inflammatory cell infiltration (Figure 5).
Int. J. Mol. Sci. 2020, 21, 272 9 of 29
Int. J. Mol. Sci. 2019, 20, x  9 of 29 
 
 
Figure 5. Haematoxylin and eosin staining of ileum (A–D) and colon (E–H; magnification ×20; scale 
bar = 200 µm) in corn starch diet-fed rats (A,E), corn starch diet-fed rats treated with Garcinia dulcis 
rind powder (B,F), high-carbohydrate, high-fat diet-fed rats (C,G) and high-carbohydrate, high-fat 
diet-fed rats treated with Garcinia dulcis rind powder (D,H). 
We used a 16S rRNA gene-based analysis to assess bacterial communities from rat faecal pellets. 
Data was obtained for five replicates of control samples (C and H) and six replicates for samples from 
rats treated with G. dulcis (CGD and HGD). After quality filtering, there were a total of 625,711 
sequences, and these were clustered into 1114 zero-radius operational taxonomic units (zOTUs). The 
calculated rarefaction curves based on rarefied and unrarefied data as well as Good’s coverage of 
99.68 ± 0.12% revealed that the majority of the bacterial community was recovered by the surveying 
effort (Figure 6). 
 
Figure 6. Rarefaction curves (A) before and (B) after normalisation (14,908 sequences). 
2.5.1. Alpha Diversity Measures (Shannon Diversity and Richness) of the Bacterial Communities 
There was no statistical support for differences in Shannon’s diversity for the four different 
dietary groups (p > 0.05) (Figure 7). There was no statistical support for any pairwise comparison of 
richness between the dietary groups, except for some marginal support for a higher richness in H rats 
compared to CGD rats (Figure 7; p = 0.0296). 
Figure 5. ae atoxylin and eosin staining of ileu (A–D) and colon (E–H; agnification ×20; scale
bar = 200 µ ) in corn starch diet-fed rats ( ,E), corn starch diet-fed rats treated ith Garcinia dulcis
rind po der (B,F), high-carbohydrate, high-fat diet-fed rats (C, ) and high-carbohydrate, high-fat
diet-fed rats treated ith arcinia dulcis rind po der ( , ).
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revealed that the majority of the b cterial community was recovered by the surveying effort (Figure 6).
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Figure 6. Rarefaction curves (A) before and (B) after normalisation (14,908 sequences).
2.5.1. Alpha Diversity Measures (Shannon Diversity and Richness) of the Bacterial Communities
There was no s atistical support for differences in Shannon’s diversity for he four differe t dietary
groups (p > 0.05) (Figure 7). There was no statistical support for any pairwise comparison of richness
between the dietary groups, except for some marginal support for a higher richness in H rats compared
to CGD rats (Figure 7; p = 0.0296).
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2.5.2. Bacterial Community Structure
An overall effect of diet (Figure 8, Table 2; Per utational multivariate analysis of variance
(PERMANOVA), p = 0.0001) and treatment (Figure 8, Table 2; PERMANOVA, p = 0.0001) was observed
on the overall bacterial community structure based on Bray–Curtis dissimilarity, as well as the
interaction of the two factors (diet and treatment) (Figure 8, Table 2; PERMANOVA, p = 0.0001).
Table 2. PERMANOVAs b sed on Bray–Curtis similarity measure for square-root transformed
abundances of all rat faecal samples.
Source df SS MS Pseudo-F p (perm) Unique Perms
Diet 1 6986.2 6986.2 7.0877 0.0001 9879
Treatment 1 7162.9 7162.9 7.267 0.0001 9905
Diet × treatment 1 2735.8 2735.8 2.7756 0.0001 9859
Res 18 17,742 985.68
Total 21 34,411
PAIR-WISE TESTS
Groups t p (perm) Unique Perms
C, C 2 216 0.00 9 462
C, H 2.6651 0.0074 126
C, HGD 2.2135 0.0026 462
CGD, H 3.2027 .001 462
CGD, HGD 1.7959 0.0018 461
H, HGD 2.2624 0.0024 461
PERMDISP (PAIRWISE COMPARISONS)
Groups t p (perm)
C, CGD 0.28079 0.8116
C, H 1.6414 0.2101
C, HGD 1.6237 0.2481
CGD, H 2.4479 0.074
CGD, HGD 1.7921 0.1642
H, HGD 2.7484 0.0338
p values were calculated using 9999 permutations under a residual model. C, corn starch diet-fed rats; CGD, corn
starch diet-fed rats treated with Garcinia dulcis rind powder; H, high-carbohydrate, high-fat diet-fed rats; HGD,
high-carbohydrate, high-fat diet-fed rats treated with Garcinia dulcis rind powder.
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Analysis of the colonic microbiota showed differences between C and H faecal samples without G.
dulcis rind powder (p = 0.0074) indicating an effect of basal diet on the bacterial community structure.
Addition of G. dulcis rind powder to either of the diets produced similar changes to the community
structure (p = 0.0019 to 0.0024 for C and H, respectively) (Figure 8). Bacterial communities in HGD
rats were also more variable between replicates compared to H rats (Figure 8, Table 2; PERMDISP;
p = 0.0338).
2.5.3. Firmicutes and Bacteroidetes Ratio as an Indicator for Obesity
Differences in the bacterial community structure were also assessed by calculating the ratio of
Firmicutes to Bacteroidetes (F/B ratio). This ratio has previously been found to positively correlate
with obesity in humans and other mammals. The data shows that diet (C or H) supplemented with G.
dulcis resulted in a reduction in F/B ratio, and this difference was more prevalent for H diet (p < 0.0001)
(Figure 9).
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rats treated with Garcinia dulcis rind powder; H, high-carbohydrate, high-fat diet-fed rats; HGD,
high-carbohydrate, high-fat diet-fed rats treated with Garcinia dulcis rind powder.
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2.5.4. Taxonomic Structure of the Bacterial Communities
The most abundant bacterial classes found in the faecal samples for different treatment groups
belonged to the classes Bacteroidia, Bacilli, Clostridia, Erysipelotrichia and Verrucomicrobia (Figure 10).
Other bacterial classes, including Actinobacteria, Coriobacteria, Melainabacteria, Deferribacteres,
Saccharimonadia, Alphaproteobacteria, Deltaproteobacteria, Gammaproteobacteria and Mollicutes,
were observed at lower abundance levels (i.e., <1%) in some (but not all) faecal samples. The relative
abundance of bacteria from the class Bacteroidia was reduced in H rats (8.96 ± 2.2%) compared to
the other groups (27.63 ± 2.2% to 36.46 ± 1.3%) (p < 0.0001). An increase in the relative abundance
of bacteria from class Bacilli was observed in C rats (2.49 ± 1.0% to 4.08 ± 1.9%) compared to H rats
(0.7 ± 0.3% to 0.75 ± 0.4%). A higher abundance of bacteria from the class Clostridia was observed for
H and HGD rats, and this was more pronounced for H rats (45.03 ± 4.8% to 76.80 ± 4.9%) compared
to C rats (37.81 ± 3.6% to 45.36 ± 3.5%) (p < 0.0001). Similarly, an increase in relative abundance of
bacteria from the class Verrucomicrobiae was observed in HGD rats (21.16 ± 3.3%) compared to CGD
rats (12.46 ± 3.6%), while a decrease in abundance was observed in H rats (4.47 ± 2.8%, p < 0.0001)
compared to C rats (13.89 ± 2.0%).
Analysis of the bacterial community structure at the family level showed that Bacteroidaceae (class
Bacteriodia), Muribaculaceae (class Bacteriodia), Prevotellaceae (class Bacteroidia), Tannerellaceae
(class Bacteroidia), Lachnospiraceae (class Clostridia), Lactobacillaeceae (class Bacilli), Clostridiaceae
(class Clostridia), Peptostreptococcaceae (class Clostridia), Ruminococcaceae (class Clostridia),
Erysipelotrichaceae (class Erysipelotricia) and Akkermansiacaeae (class Verrucomicrobia) were found
to be most dominant in the faecal samples (Figure 11). The relative abundance of bacteria from family
Ruminococcaceae was reduced for C rats (7.38 ± 1.4% to 9.75 ± 1.1%) co pared to H rats (13.77 ± 2.4%
to 14.39 ± 2.2%). A high abundance of bacteria from the family Lachnospiraceae was detected in H rats
(41.85 ± 7.3%, p < 0.0001) compared to HGD rats (23.82 ± 3.6%) and C rats (20.78 ± 3.5% to 21.11 ± 2.9%).
In contrast, the abundance of bacteria from families Muribaculaceae and Lactobacillaeceae was reduced
in H rats (Muribaculaceae: 5.5 ± 1.6% to 12.8 ± 2.1%; Lactobacillaeceae: 0.4 ± 0.1% to 0.61 ± 0.4%)
compared to C rats (Muribaculaceae: 19.9± 2.0% to 21.60± 1.2%, p < 0.05; Lactobacillaeceae: 2.34± 0.1%
to 3.98 ± 0.2%) (Figure 11). Moreover, higher abundance of bacteria from family Bacteroidaceae was
observed for both diets supplemented with G. dulcis rind powder (8.12 ± 2.8% to 8.49 ± 1.1%) compared
to controls (1.72 ± 0.4% to 2.24 ± 0.7%).
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Analysis of the bacterial community structure at the genus level showed that Bacteroides (family
Bacteroidaceae), unclassified Muribaculaeceae, Clostridium sensu stricto 1 (family Clostridiaceae),
Lachnospiraceae NK4A136 group (family Lachnospiraceae), Roseburia (family Lachnospiraceae),
Ruminococcus 1 (family Ruminococcaceae), unclassified Ruminococcaceae, Turicibacter (family
Erysipelotrichaceae) and Akkermansia (family Akkermansiaceae) were found to be most dominant in
the faecal samples (Figure 12).
Int. J. Mol. Sci. 2019, 20, x  14 of 29 
 
 
Figure 11. Taxonomic profiles of bacterial communities shown at the family level. C, corn starch diet-
fed rats; CGD, corn starch diet-fed rats treated with Garcinia dulcis rind powder; H, high-
carbohydrate, high-fat diet-fed rats; HGD, high-carbohydrate, high-fat diet-fed rats treated with 
Garcinia dulcis rind powder. 
 
Figure 12. Taxonomic profiles of bacterial communities shown at the genus level. C, corn starch diet-
fed rats; CGD, corn starch diet-fed rats treated with Garcinia dulcis rind powder; H, high-
Figure 12. Taxonomic profiles of bacterial communities shown at the genus level. C, corn starch diet-fed
rats; CGD, corn starch diet-fed rats treated with Garcinia dulcis rind powder; H, high-carbohydrate,
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2.5.5. Differentially Abundant zOTUs
Additionally, multivariate analysis of individual zOTUs using the R package Mvabund revealed
that diet and treatment, as well as the interaction between diet and treatment changed the bacterial
community structure in the faecal samples (Table 3).
A total of 19 zOTUs (1.70% of total zOTUs) belonging mostly to phylum Firmicutes were affected
by diet (Table 3, Supplementary Table S1). One zOTU belonging to the phylum Actinobacteria was
enriched in C rats (C and CGD rats), while bacteria belonging to the phylum Firmicutes and families
Lachnospiraceae (genus: [Bacteroides] pectinophilus group, Anaerostipes, Lachnospiraceae NK4A136
group, Lachnospiraceae UCG-006, Lachnospiraceae UCG-008, Roseburia), Peptostreptococcaceae and
Ruminococcaceae (genus: Ruminiclostridium 9) were either reduced or absent in C and CGD rats
(Supplementary Table S1).
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Table 3. Summary of statistical tests on differential zOTU abundance.
Global Test (GLMs) by Mvabund
Diet p < 0.0001
Treatment p < 0.0001
Diet × Treatment p < 0.0001
Univariate Analysis by mvabund (p < 0.05)
Factor Number of DifferentiallyAbundant OTUs % of Total Number of OTUs
Diet 19 1.70%
Treatment 35 3.14%
Diet × Treatment 2 0.18%
Total (unique zOTUs affected by
one or more factors) 56 5.03%
At the zOTU level, G. dulcis supplementation had a stronger effect than diet on the bacterial
community structure by affecting the abundance of 35 zOTUs (3.14% of total zOTUs) (Table 3). zOTUs
belonging to the phylum Firmicutes (families Clostridiaceae 1, Lachnospiraceae and Ruminococcaceae;
genus Clostridium sensu stricto 1, Acetitomaculum, Blautia, Lachnospiraceae NK4A136 group, Pygmaiobacter,
Ruminococcaceae UCG-010, Ruminococcaceae UCG-014 and UBA1819) were reduced in abundance or
absent in CGD and HGD samples compared to C and H rats, respectively, while zOTU belonging
to the families Lachnospiraceae (genus: unclassified) were enriched in the CGD and HGD rats
(Supplementary Table S2). Bacteria belonging to the phylum Proteobacteria and family Parasutterella
were enriched in CGD and HGD rats compared to C and H rats, while zOTUs belonging to the
phylum Patescibacteria and family Saccharimonadaceae were enriched in the control samples (C and
H) compared to samples from rats treated with G. dulcis rind powder (Supplementary Table S2).
2.5.6. Multivariate Analysis of Physiological Data
A total of twenty-three physiological parameters were assessed and included in the analysis
below (body weight, water intake, food intake, energy intake, feed efficiency, left ventricle and septum
wet weight, right ventricle wet weight, liver wet weight, kidneys wet weight, spleen wet weight,
retroperitoneal fat, omental fat, epididymal fat, total abdominal fat, plasma non-esterified fatty acids,
plasma triglycerides, fat mass, lean mass, systolic blood pressure, oral glucose tolerance area under the
curve, blood glucose concentrations at 120 min, plasma aspartate transaminase activity and plasma
alanine transaminase activity) for rats fed with C and H diets and supplemented with G. dulcis
rind powder.
Distance-based multivariate analysis shows that treatments have distinct responses on the
physiological parameters. An overall effect of diet (Supplementary Figure S1, Supplementary Table
S3; PERMANOVA, p = 0.0002) and treatment (Supplementary Figure S1, Supplementary Table S3;
PERMANOVA, p = 0.0001) was observed on physiological states of rats.
There was statistical support for differences between C and H rats without G. dulcis rind powder
(p = 0.0083) indicating an effect of basal diet on physiological parameters of rats. There was also
an effect for the addition of G. dulcis to either of the diets (p = 0.0015 to 0.0023 for C and H,
respectively, Supplementary Table S3), and these changes appear to be similar (Supplementary Figure
S1). Rat physiological states in CGD group were more variable between replicates compared to C
group (Supplementary Figure S1, Supplementary Table S3; PERMDISP; p = 0.0342) and H group
(Supplementary Figure S1, Supplementary Table S3; PERMDISP; p = 0.0028).
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2.5.7. Correlation of Microbiota and Physiological Parameters
Combined analysis of bacterial community structure and physiological parameters were performed,
and Mantel test showed that overall the bacterial community structure and the physiological data
are correlated (Mantel statistic r = 0.3739; p = 0.0004). Among the physiological parameters, water
intake, energy intake, feed efficiency, oral glucose tolerance test area under the curve, kidneys and liver
weights and plasma triglycerides had the strongest correlation with bacterial community structure
(Supplementary Figure S2).
Energy intake, oral glucose tolerance test area under the curve and systolic blood pressure
correlated with the changes in the bacterial community structure for both C and H diet in response to
G. dulcis supplementation. Total abdominal fat, energy intake, plasma non-esterified fatty acids, fat
mass, retroperitoneal fat, epididymal fat, omental fat, body weight gain, feed efficiency, left ventricle
wet weight, food intake, plasma triglycerides and kidney wet weight were correlated with the changes
in the bacterial community structure for the C diet in response to the G. dulcis supplementation,
while water intake was correlated with changes in the bacterial community structure for the H diet in
response to the G. dulcis supplementation (Supplementary Table S4).
When physiological variables were further correlated with individual zOTUs, a total of 40 zOTUs
were found to be correlated with at least 1 of the 17 physiological parameters (p < 0.05). 32 zOTUs
belonged to the phylum Firmicutes, five zOTUs to the phylum Bacteroidetes, two zOTUs to the phylum
Proteobacteria and one zOTU to the phylum Actinobacteria. Total abdominal fat (five of 40 zOTUs or
12.5%) and energy intake (seven of 40 zOTUs or 17.5%) were inversely correlated with the relative
abundance of the selected zOTUs. Similarly, systolic blood pressure (one of 40 zOTUs or 2.5%) and
oral glucose tolerance area under the curve (five of 40 zOTUs or 12.5%) were positively correlated with
the selected zOTUs (Supplementary Table S5).
The relative abundances of zOTUs belonging to the phylum Firmicutes and the families
Clostridiaceae 1 (genus Clostridium sensu stricto 1: zOTU3, zOTU1064), Lachnospiraceae (genus
Acetitomaculum, Anaerostipes, Blautia, Coprococcus 2, Lachnospiraceae NK4A136 group, Lachnospiraceae
UCG-006, Lachnospiraceae UCG-008, Roseburia, Peptostreptococcaceae and Ruminococcaceae: zOTU410,
zOTU131, zOTU372, zOTU247, zOTU1122, zOTU400, zOTU156, zOTU118, zOTU162, zOTU70,
zOTU166 and zOTU555) were inversely correlated with the physiological parameters included in this
analysis, with the exception of water intake.
In contrast, several zOTUs belonging to the phylum Firmicutes (unclassified Lachnospiraceae)
(zOTU304, zOTU469, zOTU473 and zOTU658) were positively correlated to the physiological
parameters liver wet weight and oral glucose tolerance area under the curve (Supplementary Table S5).
Further, the relative abundances of bacteria belonging to phylum Actinobacteria and family
Bifidobacteriaceae; phylum Proteobacteria and family Parasutterella; and phylum Bacteroidetes and
family Tannerellaceae (for example: zOTU24, zOTU477, zOTU343, zOTU46, zOTU211, zOTU28,
zOTU21 and zOTU230) were positively correlated to the physiological parameters including kidneys
wet weight, liver wet weight, plasma triglycerides, plasma non-esterified fatty acids, oral glucose
tolerance area under the curve and total abdominal fat (Supplementary Table S5).
3. Discussion
Garcinia dulcis is a tropical fruit used in Southeast Asia mainly for medicinal properties and
occasionally as food, although the sour taste is a challenge in commercialising the fruit without
processing [21]. G. dulcis fruit has a thick rind in proportion to the whole fruit, comparable to G.
mangostana and G. humilis [20,22]. The rind and seed which form about 60% of the total fruit weight
are rarely used and so these are regarded as waste. The rind, skin, seed and pomace contain bioactive
compounds such as polyphenols, fibre, vitamins, enzymes and oils [23]. Hence, evidence for health
benefits for these phytochemicals could assist commercialisation as well as reduce waste and the
resulting environmental problems through decomposition.
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Garcinol, morelloflavone and citric acid are the main phytochemical constituents of G. dulcis
rind [24,25]. Garcinol is found in other Garcinia species such as G. cambogia, G. bancana and G. indica while
citric acid is also common in species such as G. cowa, G. indica, G. pedunculata and G. humilis [20,26,27].
Hydroxycitric acid was not found in the rind, although this compound is common in other Garcinia
species and has been proposed as an intervention for weight loss [28]. The doses of morelloflavone,
garcinol and citric acid in this study in HGD rats were 5.4 mg/kg/day, 130 mg/kg/day and 480 mg/kg/day,
respectively. These doses translate to an approximate intake of 52 mg/day, 1.26 g/day and 4.67 g/day
of morelloflavone, garcinol and citric acid, respectively, in an adult human [29]. This translates to
approximately 23 g of dried rind or 135 g of fresh rind, which is approximately the rind from two
fresh fruits; these amounts suggest that partial purification may be necessary to produce a more
concentrated nutraceutical product. Garcinol as the main polyisoprenylated benzophenone found
in G. dulcis rind has been studied as an anti-cancer agent [30] while morelloflavone had beneficial
effects on cardiovascular health [11]. Citric acid from Garcinia fruit could act synergistically with both
garcinol and morelloflavone to improve cardiovascular parameters [20].
Although there are limited in vivo studies on the effects of G. dulcis rind and its constituents
on metabolic syndrome, many studies discuss garcinol and its anti-cancer properties [12,31]. As an
example, 0.05% garcinol in diet for 5 weeks reduced the incidence of colon carcinogenesis by 40.2% in
rats with inflammation-induced colonic aberrant crypt foci [32]; this dose would correspond to about
25 mg/kg/day in an obese 500 g rat eating 25 g food/day. Garcinol showed its anti-cancer properties
through its effects on inflammatory pathways, apoptotic pathways, epigenetic control, proliferation,
angiogenesis and metastasis [30].
An in vitro study found that garcinol showed potential inhibition of lipid accumulation in
adipocytes by dose-dependently inhibiting the cell population growth of 3T3-L1 cells [33]. In these
preadipocytes, garcinol decreased C/EBPα and PPARγ expression, increased mRNA expression of
adiponectin, and reduced expression of leptin, resistin and fatty acid synthase [33]. These findings
could explain mechanisms responsible for the reduction of abdominal fat and adipocyte size reductions
observed in our study. Administration of garcinol (25, 50 and 100 mg/kg/day) to streptozotocin-induced
diabetic rats reduced concentrations of triglycerides, total cholesterol, LDL and VLDL while increasing
HDL concentrations [34]. G. dulcis fruit extract reduced total cholesterol, triglyceride and LDL
concentrations, and increased HDL concentrations [35]. Similarly, we found reduction of triglycerides
and non-esterified fatty acids but without changes in total cholesterol concentrations.
The intake of 0.05% of garcinol per day in male F344 rats improved anti-oxidant and
anti-inflammatory effects by decreasing expression of iNOS and COX-2 [32]. In addition, garcinol
inhibited the generation of NO and O2− species [32]. The inhibition of iNOS and COX-2 generation by
garcinol was suggested due to the blocking of lipopolysaccharide-induced NF-κB production through
suppression of IκBα and p38 mitogen-activated kinase [36]. These studies suggest that the changes in
physiological and metabolic parameters observed in our study were due to a reduction in inflammatory
and oxidative stress responses.
The present study showed an improvement of glucose tolerance and insulin response in HGD rats.
Administration of 20 mg/kg/day of garcinol in streptozotocin-induced diabetic Wistar rats reduced
fasting blood glucose concentrations [37]. Additionally, administration of 100 mg/kg/day of garcinol
reduced HbA1c and blood glucose concentrations in streptozotocin-induced diabetic female Wistar
rats [34].
In this study, we also found improvements in liver structure and function by decreased collagen
deposition and reduced aspartate transaminase activity in HGD rats compared to H rats, similar to a
previous study with G. dulcis fruit rind [8]. In addition, administration of 20 mg/kg/day of garcinol
decreased aspartate transaminase and alanine transaminase activities compared to diabetic rats [37].
The reduction of liver fibrosis and collagen deposition by garcinol treatment was also noted here.
Garcinol administration reduced aspartate transaminase activity and showed hepatoprotective and
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anti-fibrotic effects by reducing accumulation of extracellular matrix and expression of α-smooth
muscle actin, TGF-β1 and Smad 2/3 proteins in dimethylnitrosamine-induced liver fibrosis in rats [38].
Treatment with G. dulcis rind powder showed cardioprotective effects in HGD rats. Administration
of cyclodextrin-garcinol complex (20 mg/kg/day) in isoproterenol-induced cardiotoxicity showed
marked cardioprotective activity through reduction of myocardial hypertrophy and concentrations
of malondialdehyde and increased glutathione [39]. Garcinol (50 µmol/L for 24 h) inhibited the
intrinsic histone acetyl-transferase activity of CBP/p300 and suppressed the expression of collagen I in
fibroblasts [40], which could explain the reduction of collagen deposition in both heart and liver in
HGD rats and the reduction in cardiac stiffness observed in our study.
Further, morelloflavone isolated from G. dulcis fruits has diuretic and hypotensive effects [41].
The combination of morelloflavone and 7-epiclusianone at a dose of 10.76 mg/rat and 42 mg/rat,
respectively, from G. brasiliensis ethanol extract reduced body weight and liver weight compared to
control high-fat diet [42]. Morelloflavone and 7-epiclusianone in the peel extract increased β-oxidation
and decreased fatty acid synthesis to decrease steatosis and liver damage [42]. Morelloflavone
counteracted restenosis by blocking injury-induced neointimal hyperplasia through the inhibition
of vascular smooth muscle cell migration [43]. The inhibition of morelloflavone on vascular smooth
muscle cell migration was due, in part, to its inhibition of the activation of migration-related kinases,
including focal adhesion kinase, C-SRC, extracellular signal-related kinase and RhoA in vascular
smooth muscle cells [43]. In isolated rat thoracic aorta, cumulative addition of 10−9 to 10−5 M of
morelloflavone from G. dulcis dose-dependently relaxed noradrenaline-precontracted rat thoracic
aorta [44]. In addition, the anti-atherogenic effects of morelloflavone from an extract of G. dulcis leaves
at doses of 0.005% and 0.01% in hypercholesterolaemic rabbits were shown by reductions in plasma
cholesterol and triglycerides and reduction in atheromatous lesions [10]. However, there are limited
studies on the in vivo effects of morelloflavone in rodents.
Gut microbiota analysis showed marked changes on the structure of colonic bacterial communities
in H rats compared to C rats; the communities of both C and H rats were changed by addition of
G. dulcis rind powder to the diet. The gut microbiota in obese subjects in both human and high-fat
diet-fed mice showed increased F/B ratio [45]. In this study, the F/B ratio was decreased in HGD rats
compared to H rats similar to the finding from previous study using garcinol [46].
The decrease in relative abundance of class Bacteroidia in H rats agrees with a previous study
using high-fat diet [47]. G. dulcis treatment reduced relative abundance of class Clostridia compared to
H rats. The relative abundance of class Verrucomicrobiae and Bacteroidetes (Bacteroidia) was increased
in HGD rats and C rats compared to H rats, similar to previous study showing the increase in this class
when a high-fat diet was added with garcinol [46]. At family level, the addition of G. dulcis increased
the population of Akkermansiaceae, Lachnospiraceae and Bacteroidaceae. This finding was also
found in a previous study using garcinol as treatment in high-fat diet, except for Lachnospiraceae [46],
suggesting that garcinol present in G. dulcis rind modulated the microbiota in H rats. At genus level,
the increase in relative abundance of Akkermansia and Bacteroides in HGD rats was also previously
found [46]. The multivariate analysis showed that zOTUs belonging to the phylum Firmicutes were
reduced in their relative abundances in CGD and HGD rats, which explains the reduction of F/B ratio
in these samples.
In this study, the bacterial community structures are found to correlate with individual
physiological parameters. When compared with individual zOTU, Bifidobacterium was positively
correlated with obesity-related parameters. However, Bifidobacterium was found to have protective
effects against obesity in high-fat diet-fed rats [48]. Furthermore, Bifidobacterium and Akkermansia
among others are more prevalent in individual with lean phenotypes while Bacteroides, Anaerostipes
and Ruminococcus are more prevalent in obese individuals [49].
Furthermore, the genus Lachnospiraceae NK4A136 group was positively correlated with area under
the curve for blood glucose concentration. Previous study showed that Lachnospiraceae was positively
associated with diabetes [50]. Additionally, the abundance of Bacteroides and Parabacteroides was
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positively correlated while Roseburia was negatively correlated with fasting blood glucose and area
under the curve in obese diabetic ob/ob mice fed with capsaicin [51].
The relative abundance of genus Acetitomaculum was positively correlated with normalised
left ventricle and septum wet weight, which indicate reduced cardiac hypertrophy but Anaerostipes,
Lachnospiraceae NK4A136 group and Lachnospiraceae UCG-008 were negatively correlated with this
parameter. In animal studies, Eubacteria, Anaeroplasma, Roseburia, Oscillospora and Dehalobacteria were
found to be active in preventing atherosclerosis, while the absence of microbiota could increase
the formation of atherosclerotic lesion [52,53]. Other bacteria such as Porphyromonas gingivalis
and Aggregatibacter actinomycetemcomitans increased the progression of atherosclerosis in an animal
model [52].
Blood pressure is closely linked to the diversity, richness and evenness of the microbiota living in
the gut and is affected by the F/B ratio [52]. Further, a gut metabolite trimethylamine N-oxide (TMAO)
was identified as a major affecting factor in cardiovascular disease [52] with TMAO playing a role in
the development of cardiac hypertrophy and cardiac fibrosis [54]. Other than TMAO, gut metabolites
such as secondary bile acids, indoxyl sulphate, p-cresyl sulphate and phenylacetyl-glutamine can also
influence cardiovascular disease risk [52].
Dysbiosis of the gut microbiota has been associated with non-alcoholic fatty liver disease [55].
Increased liver weight was correlated with the increased deposition of hepatic fat and inflammation [18].
Here, the genus Parabacteroides and the family Lachnospiraceae were positively associated with
normalised liver wet weight but the genus Clostridium sensu stricto 1 and Acetitomaculum were negatively
associated. Analysis of the gut microbiota in non-alcoholic fatty liver disease patients showed a lower
percentage of Bacteroides and higher amounts of Prevotella and Porphyromonas species compared to
lean controls [56]. The decreases in Lachnospiraceae, Lactobacillaceae and Ruminococcaceae have been
observed in patients with non-alcoholic fatty liver disease [57]. The change in gut microbiota promotes
the development of non-alcoholic fatty liver disease by facilitating processes of inflammation, insulin
resistance, bile acids and choline metabolism, changing intestinal permeability, production of ethanol
in the intestine and interaction with innate immunity [55,58].
In this study, we did not find any abnormal changes in gastrointestinal or liver structures, which
indicates that the doses given in this study were not toxic. The no-observed-adverse-effect level value
for repeated dose toxicity for citric acid in rats was 1200 mg/kg/day [59], which is higher than the dose
given in this study. Acute administration of garcinol was safe to use up to 2000 mg/kg body weight in
Wistar rats [60]. Sub-chronic garcinol dosage for 90 days showed no-observed-adverse-effect level value
of 100 mg/kg/day without changes in gross histopathological or other biochemical parameters [60],
which is around two thirds of the dose in HGD rats. Further, repeated administration of 300 mg/kg of
garcinol did not produce any signs of toxicity or increased mortality [34]. The LD50 in rats of garcinol
was taken as 1000 mg/kg [34]. Administration of 8 mg/kg/day of morelloflavone in mice showed no
observed toxicity [61]; this dose was higher than the dose given in this study of 5.4 mg/kg/day.
The markedly decreased body weight in treated rats can be associated with the reduction in food
intake, so this could suggest that the combination of citric acid, garcinol and morelloflavone in G. dulcis
rind triggers the appetite satiety mechanisms that inhibit food intake, although there are no studies on
these responses. Possible mechanisms include similar responses as hydroxycitric acid which reduced
appetite and body weight in human subjects [62], increased release of serotonin from rat brain cortex
slices [63] and inhibited serotonin uptake [64].
4. Materials and Methods
4.1. Garcinia dulcis Rind, Pulp and Seed Preparation and Analyses
G. dulcis fruits were obtained from South Johnstone Research Facility (Centre for Wet Tropics
Agriculture, Boogan, QLD, Australia). The fruits were then separated into rind, pulp and seed and
weighed. The rind, pulp and seeds were frozen separately at −20 ◦C before freeze-drying and grinding
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into powder. Samples of rind, pulp and seed powder were analysed to identify the compounds
present. The remaining powders were kept at 4 ◦C until further use. Analyses were performed on an
Agilent 1200 series HPLC system consisting of a diode array detector (G4212B), binary pump (G4220A),
an autosampler (G4226A), a vacuum degasser and a column oven. All solvents and reagents used
were HPLC or analytical grade. For analysis of garcinol and morelloflavones, the column was linked
to an Agilent 6130 single quadrupole mass spectrometer as detector (Agilent Technologies Australia,
Mulgrave, VIC, Australia).
4.1.1. Citric Acid Analysis
Analysis of organic acids was based on the 2016 United States Pharmacopeia (USP) Garcinia
hydroxycitric acid method. All reagents and solvents were HPLC grade with Milli-Q water. Mobile
phase was 0.136% (w/v) potassium dihydrogen phosphate in 3% phosphoric acid adjusted to pH 2.5.
Briefly, about 250 mg of the extracts was weighed and extracted in 5 mL of 3% phosphoric acid with
sonication for 15 min. After centrifuging for 5 min, an aliquot of the supernatant was taken up in
a HPLC vial and run against reference standards of hydroxycitric acid calcium salt, citric acid and
malic acid.
The analysis was performed using a Phenomenex 250 mm C18 column with 1 mL/min of isocratic
mobile phase over 25 min. Reference standards were injected and prepared as a calibration curve
for calculation of the hydroxycitric acid and citric acid concentrations. For the hydroxycitric acid
measurements, the rind of Garcinia quaesita was held as a reference sample at Analytical Research
Laboratory, Southern Cross University, Lismore, NSW, Australia for herbal authentication.
4.1.2. Garcinol Analysis
The chromatography was performed with a Phenomenex Kinetex C18 HPLC column (100× 4.6 mm)
using a gradient method [65]. Dried ground rind, pulp and seed were quantitatively extracted by
mixing 0.2 to 0.25 g with 25 mL of acetonitrile in a volumetric flask sonicated for 30 min. An aliquot
of the solvent sample was centrifuged and 200 µL of the supernatant was taken into HPLC vial for
analysis. The mobile phases were solvent A (0.1% formic acid, Milli-Q water) and solvent B (acetonitrile
with 0.1% formic acid); optimal separations were obtained using a gradient of 60% to 95% B over
0–28 min, with flow rate of 0.75 mL/min.
Reference standard of garcinol (Sigma-Aldrich Australia, Castle Hill, NSW, Australia) was prepared
in acetonitrile at 0.4 mg/mL, then diluted to produce a five-point calibration curve. Quantification was
performed based on calibration curve of reference standards, peak area at 240 nm and sample dilution.
Total benzophenones were calculated as garcinol and results were expressed as % w/w.
4.1.3. Morelloflavone Analysis
The chromatography was performed on a Phenomenex luna C18 HPLC column (100 × 4.6 mm)
using a gradient method of water and acetonitrile with 0.005% trifluoroacetic acid over 28 min. The
solvent gradient for separation of target constituents started at 10% acetonitrile increased as a gradient
to 95% acetonitrile over 18 min, at a flow rate of 0.75 mL/min and an injection volume of 5 µL.
Morelloflavones are biflavones of naringin (flavonone) and luteolin (flavone) units, hence naringin was
used as the reference standard for calculating the quantity of morelloflavones. Calibration standards of
naringin (Sigma-Aldrich Australia) were prepared in water, at concentrations from 0.01 to 0.4 mg/L.
Specific detection and calibration curves for each compound were performed at 280 nm. Quantification
was performed using the Chemstation software (Agilent Technologies Australia) based on reference
standards, peak area and sample dilution at a specific wavelength of 280 nm for each peak identified
as a biflavonone or glycoside.
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4.2. Rats and Diets
A total of 48 male Wistar rats (8–9 weeks old) were obtained from the Animal Resource Centre,
Murdoch, WA, Australia. Rats were housed individually in a temperature-controlled room (22 ± 2 ◦C)
under 12-h light/dark cycle environment at the University of Southern Queensland animal house with
free access to food and water. All experimental protocols were approved by the University of Southern
Queensland Animal Ethics Committee (project number: 16REA014; approved on 30 September 2016),
which operates under the guidelines of the Australian National Health and Medical Research Council.
Rats were allowed to adapt for a week and upon reaching 330–340 g body weight (337± 1 g body weight,
n = 48), they were randomly allocated into 4 experimental groups (n = 12 per group) and fed with
corn starch diet (C), corn starch diet with 5% (w/w) G. dulcis rind powder (CGD), high-carbohydrate,
high-fat diet (H) or high-carbohydrate, high-fat diet with 5% (w/w) G. dulcis rind powder (HGD).
Rats in C and CGD received corn starch diet for the first 8 weeks, and H and HGD groups received
high-carbohydrate, high-fat diet for the first 8 weeks. C and H diet compositions have been previously
reported; both contain about 68% carbohydrate as corn starch in the C diet and as condensed milk and
fructose in the H diet with 24% fat in the H diet mainly as beef tallow compared to ~1% fat in the C
diet [18]. G. dulcis rind powder was added to groups CGD and HGD for the last 8 weeks while C and
H rats were kept on their respective diets without supplementation for the whole 16-week protocol.
Moreover, H and HGD rats were supplied with 25% (w/v) fructose in drinking water. Body weight and
intakes of water and food were recorded daily by weighing of rats individually, and their remaining
food and water, and feed efficiency was calculated [18]. Daily energy intake was calculated from the
daily food and water intakes during the last 8 week of protocol [18]. The % increase in body weight
was calculated as the difference in body weight between week 8 and week 16.
4.3. Measurements in Living Rats
Oral glucose tolerance tests were conducted after overnight (12 h) food deprivation at weeks 8
and 16 with fructose water in H and HGD groups substituted with normal water. After measuring
basal blood glucose concentrations in tail vein blood using glucometer (Freestyle lite, Abbot Diabetes
Care, Doncaster, VIC, Australia), rats were given 2 g/kg glucose through 40% aqueous glucose solution
by oral gavage and blood glucose concentrations were measured in tail vein blood at 30, 60, 90 and
120 min after glucose loading [18].
Insulin tolerance tests were performed at 8 and 16 weeks of protocol. Rats were deprived of food
five hours prior to the procedure. Fructose water in H and HGD groups was replaced with normal
drinking water. After measuring basal blood glucose concentrations in tail vein blood using glucometer
(Freestyle lite, Abbot Diabetes Care, Doncaster, VIC, Australia), 0.33 IU/kg insulin (Humulin R, Eli Lilly
Australia, West Ryde, NSW, Australia) was administered intraperitoneally. Glucose concentrations
in tail vein blood samples were measured at 30, 60, 90 and 120 min following insulin administration.
The rats were withdrawn from the protocol when plasma glucose concentrations dropped below
1.1 mmol/L and were immediately gavaged with 5 mL of 50% aqueous glucose solution.
Dual-energy X-ray absorptiometry measurements were performed on rats at 8 and 16 weeks
using a Norland XR46 DXA instrument (Norland Corp., Fort Atkinson, WI, USA) [18]. Rats were
anaesthetised using isoflurane (Lyppard Australia Ltd. Pty, Northgate, QLD, Australia).
Whole body metabolism was measured at 16-week using 4 chamber OxyMax system (Columbus
Instruments, Columbus, OH, USA) by placing one rat per chamber. Rats had free access to food and
water during the experiment. Carbon dioxide production (VCO2) and oxygen consumption (VO2) were
determined from each chamber. Respiratory exchange ratio (VCO2/VO2) was quantified by OxyMax
software (v. 4.86). Energy expenditure was quantified based on the exchange of oxygen for carbon
dioxide that occurs during metabolism of food [66].
Systolic blood pressure was measured at 8 and 16 weeks with rats lightly sedated with isoflurane
(Lyppard Australia Ltd. Pty). Measurements were performed using an MLT1010 Piezo-Electric Pulse
Transducer (ADInstruments, Bella Vista, NSW, Australia) and an inflatable tail-cuff connected to an
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MLT844 Physiological Pressure Transducer (ADInstruments) connected to a PowerLab data acquisition
unit (ADInstruments) [18].
4.4. Measurements after Euthanasia
The isolated Langendorff heart preparation evaluated left ventricular function in rats [18].
Intraperitoneal Lethabarb (pentobarbitone sodium, 100 mg/kg; Virbac, Peakhurst, NSW, Australia) was
used to induce terminal euthanasia. Following euthanasia, heparin (~200 IU, Sigma-Aldrich Australia)
was injected into the right femoral vein. Blood (~5 mL) was then drawn from the abdominal aorta and
kept in heparinised tubes. Isovolumetric ventricular function was assessed by inserting a latex balloon
catheter into the left ventricle of the isolated heart attached to a Capto SP844 MLT844 physiological
pressure transducer and Chart software on a MacLab system (ADInstruments) [18]. Heparinised
blood was centrifuged at 5000× g for 10 min within 30 min of collection. Plasma was stored at −20 ◦C.
Plasma concentrations of triglycerides, non-esterified fatty acids and total cholesterol, and plasma
activities of aspartate transaminase and alanine transaminase were measured using kits and standards
supplied by Olympus (Tokyo, Japan) using an AU 400 Olympus analyser [18]. Plasma C-reactive
protein concentrations were determined using a commercial ELISA kit (BD Bioscience, North Ryde,
NSW, Australia).
Organ weights were measured for right and left ventricles, liver and retroperitoneal, epididymal
and omental fat pads shortly after euthanasia. Retroperitoneal, epididymal and omental fat pads were
included together as total abdominal fat. Organ weights were normalised relative to the tibial length at
the time of their removal (in mg/mm) [18].
For histological analysis, heart, liver, ileum and colon portions were collected about 5–7 min after
euthanasia and fixed in 10% neutral buffered formalin for 3 days. The samples were dehydrated using
an automated tissue processor and embedded in paraffin wax. Thin sections (~5 µm) of tissues were
cut and stained with haematoxylin and eosin or picrosirius red stain. Haematoxylin and eosin stained
sections were examined using an EVOS FL Colour Imaging System (v 1.4 (Rev 26059); Advanced
Microscopy Group, Bothell, WA, USA) to observe infiltration of inflammatory cells in liver and heart
and for determining fat vacuoles in liver [18]. Left ventricular and liver sections were stained with
picrosirius red to study collagen distribution using BX53 Olympus microscope (Olympus, Eagle Farm,
QLD, Australia) [18].
About 0.5 cm2 of retroperitoneal adipose tissue was fixed in 10% neutral buffered formalin
and kept at 4 ◦C for at least 72 h. The formalin was then discarded and replaced with 70% ethanol
solution. Tissue was sectioned about 10 µm thick and stained with haematoxylin and eosin stain [67].
Sectioned slides were observed using EVOS FL Colour Imaging System to observe deposition of fat.
Mean adipocyte area and adipocyte area distribution were calculated using ImageJ [68] and Prism
Version 6.00.
Small liver portions were embedded in Tissue-Tek O.C.T. Compound (ProSciTech, Kirwan, QLD,
Australia) and stored in −20 ◦C. Tissue was sectioned using a cryostat (10 µm), air-dried and stained
using Oil red O stain. Stained sections were observed using EVOS FL Colour Imaging System to
observe deposition of fat. Mean liver fat vacuoles area was calculated using ImageJ [68]. Liver glycogen
and plasma catalase activity were measured using published methods with modifications [69,70].
Faecal samples for microbiota analysis were collected from the colon using clean forceps after
euthanasia and stored in Eppendorf tubes at −80 ◦C. Faecal samples for lipid content analysis
were collected from the cage on the morning of euthanasia and stored in Eppendorf tubes at
−20 ◦C [71]. For lipid analysis, 1 g of faeces were air-dried and homogenised in 5 mL saline
solution. The homogenisation process produced a suspension that was mixed with 5 mL of 2:1 (v/v)
chloroform:methanol mixture and centrifuged at 1000× g for 10 min. After centrifugation, the lower
liquid phase was separated and transferred into a pre-weighed test tube. The lipids were air-dried
and weighed.
Int. J. Mol. Sci. 2020, 21, 272 23 of 29
4.5. Gut Microbiota Analysis
Gut microbiota diversity profiling was performed based on 16S rRNA gene sequencing on rat
faecal samples collected at euthanasia and stored at −80 ◦C.
4.5.1. DNA Extraction of Microbial Samples
Total microbial community DNA was extracted from faecal samples using the DNeasy Powersoil
Kit (Qiagen Australia, Chadstone, VIC, Australia) following the manufacturer’s instructions and
protocol published previously [72].
4.5.2. 16S rRNA Gene Amplification and Sequencing
Bacterial communities from faecal samples were investigated by sequencing 16S rRNA gene
amplicons. Below mentioned primers, 341F and 785R were used to amplify the V3-V4 regions of the
16S rRNA gene.
341F (TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG)
785R (GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC)
The reaction mixture (50 µL total volume per sample) consisted of Econotaq® PLUS GREEN 2×
Master Mix (Astral Scientific, Gymea, NSW, Australia) (25 µL), Ambion® nuclease-free water (17 µL),
the primer pair 341F and 785R (1.5 µL of each; 10 µM) and DNA template (5 µL). The PCR program
consisted of an initial denaturation at 94 ◦C (2 min), followed by 35 cycles of denaturation at 94 ◦C
(30 s), annealing at 55 ◦C (30 s) and extension at 72 ◦C (40 s) and a final extension of 72 ◦C (7 min). PCR
products were then quantified using gel electrophoresis. Paired-end sequencing (2 × 300 bp) of the
resulting 16S rRNA gene amplicons was performed at the Ramaciotti Centre for Genomics, University
of New South Wales on an Illumina MiSeq platform as per the MiSeq System User Guide [73].
4.5.3. 16S rRNA Gene Sequencing Analysis
Sequence data were initially quality-filtered and trimmed using TRIMMOMATIC version
0.36 truncating reads if the quality dropped below 20 in a sliding window of 4 bp [74]. USEARCH
version 11.0.667 [75] was used for further processing [76] to merge and quality-filter sequencing reads,
excluding reads with <250 or >550 nucleotides, in addition to reads with more than one ambiguous
base or an expected error of more than 1. Filtered sequences were denoised and clustered into unique
sequences (zOTUs) using the UNOISE algorithm [77] implemented in USEARCH. zOTU represent
unique bacterial entities and are roughly equivalent to species or strains. Chimeric sequences were
removed de novo during clustering and subsequently in reference mode using UCHIME [78] with
the SILVA database (https://www.arb-silva.de/browser/) (SILVA SSURef 132 NR) as a reference [79].
zOTUs were then taxonomically classified (i.e., assigned a likely taxonomic name) by BLASTN [80]
against the SILVA database. All non-bacterial OTUs were removed along with non-BLAST aligned
and singleton zOTUs. Finally, processed sequences were mapped on zOTU sequences to calculate
the distribution and counts of each zOTU in every sample. Only zOTUs occurring in more than two
samples were considered for further statistical analysis.
4.6. Statistical Analysis
4.6.1. Physiological and Metabolic Parameters
These data are presented as mean ± standard error of the mean (SEM). Data from C, CGD, H
and HGD groups were assessed by two-way analysis of variance. When interaction and/or the main
effects were significant, means were compared using Newman–Keuls multiple comparison post hoc
test. p value of <0.05 was defined as statistically significant. All statistical analyses were performed
using Prism version 6.00 for Windows (GraphPad Software, San Diego, CA, USA).
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4.6.2. Microbiota Community Analysis
Rarefaction curves were generated using the rarecurve function in vegan [81] and used to determine
if a sufficient representation of the sample’s microbiota had been achieved given the sequencing effort.
Prior to further analysis, the numbers of sequences were standardised across samples to account for
different sequencing depths by randomly subsampling each sample to the lowest number of sequences
counts obtained for any given sample (i.e., 14,908 counts). Bacterial alpha-diversities (i.e., zOTU
richness and Shannon’s diversity) were calculated in R (version 3.5.3) using the rrarefy function in the
vegan package for community ecology analysis [82]. A one-way analysis of variance test in GraphPad
Prism 8.0.2 (San Diego, CA, USA) followed by Tukey’s pairwise comparisons test was used to determine
the significance between the different groups, a p value <0.05 was considered to be significant.
For multivariate analysis of bacterial communities, zOTU table was imported into PRIMER [83]
to compare the community structure (i.e., relative abundance data). Bray–Curtis similarity coefficients
were calculated using square-root transformed zOTU abundances, and the resulting similarity matrix
was visualised using nMDS. PERMANOVA [84] with 9999 random mutations was used to test the
effect of diet and treatment on bacterial communities in rat faecal samples.
For multivariate analysis of physiological data, the table of physiological variables was imported
into PRIMER [83]. Euclidean distance matrix coefficients were calculated using physiological data,
and the resulting similarity matrix was visualised using nMDS. PERMANOVA [84] with 9999 random
mutations was used to test the effect of diet and treatment on the physiological data in rat faecal samples.
To determine which microbial zOTUs were affected by diet, treatment and the interaction of the
two factors, a two-factor design was used to adjust the data to a Multivariate Generalised Linear Model
(MGLM) using the multivariate package MVabund [85]. Each OTU was treated as a variable fitted to a
separate Generalised Linear Model (GLM) using a negative binomial distribution. An adjusted p value
of <0.05 was considered to be significant.
4.6.3. Correlation Analysis
The physiological parameters that contributed the most to the differences in the bacterial
community structure were investigated using the functions envfit and bioenv in the R package
vegan. Moreover, a correlation analysis was carried out using the rcorr function in the Hmisc package.
A Pearson correlation coefficient was used to identify the individual zOTUs that were linearly correlated
with the physiological parameters.
5. Conclusions
G. dulcis rind as a waste product from a widespread tropical fruit has potential to be developed as
a source of nutraceuticals including garcinol, morelloflavone and citric acid to attenuate metabolic
syndrome, especially obesity, by improving diet-induced cardiovascular, liver, metabolic and gut
microbiota changes. We suggest that the observed effects were due to the additive effects of garcinol,
citric acid and morelloflavone. A combination of anti-inflammatory and anti-oxidant responses
with appetite suppression allows multiple symptoms to be targeted. Hence, further studies should
be conducted to find feasible methods to store and then process the fruit rind, and to extract the
phytochemicals from the fruit rind to produce sustainable, low-cost interventions for metabolic
syndrome [86].
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C Corn starch diet-fed rats
CGD Corn starch diet-fed rats supplemented with Garcinia dulcis rind powder
F/B Ratio of Firmicutes/Bacteriodetes
H High-carbohydrate, high-fat diet-fed rats
HGD High-carbohydrate, high-fat diet-fed rats supplemented with Garcinia dulcis rind powder
GLM Generalised linear model
HPLC High-performance liquid chromatography
MGLM Multivariate generalised linear model
nMDS Non-metric, multi-dimensional scaling
PERMANOVA Permutational multivariate analysis of variance
SEM Standard error of the mean
TMAO Trimethylamine N-oxide
USP United States Pharmacopeia
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